Medis ehf.

About Medis ehf.

Medis is a leader in pharmaceutical development and out licensing, offering a broad portfolio of quality pharmaceutical products and comprehensive registration dossiers and intellectual property since 1985. Medis is a powerful partner with a proven track record in securing regulatory approval prior to patent expiries, and has obtained marketing authorizations in over 140 countries to date. We out-license products from the pipeline of our parent company, Teva. Medis ehf is 100% owned by Teva Pharmaceutical Industries Ltd (NYSE, TASE: TEVA).

We o...

  • IS
  • 2015
    On CPHI since
  • 2
Company types
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Medis ehf. (1)

  • Out-licensing

    Product Out-licensing

    Medis is an established provider of dossiers and products in all areas of the world with launches and marketing authorizations in over 140 countries to date.

Medis ehf. Resources (1)